Iddo Magen

2.7k total citations
38 papers, 2.0k citations indexed

About

Iddo Magen is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, Iddo Magen has authored 38 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 11 papers in Physiology and 9 papers in Molecular Biology. Recurrent topics in Iddo Magen's work include Parkinson's Disease Mechanisms and Treatments (10 papers), Cannabis and Cannabinoid Research (8 papers) and Alzheimer's disease research and treatments (6 papers). Iddo Magen is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (10 papers), Cannabis and Cannabinoid Research (8 papers) and Alzheimer's disease research and treatments (6 papers). Iddo Magen collaborates with scholars based in Israel, United States and Germany. Iddo Magen's co-authors include Marie‐Françoise Chesselet, Yosefa Avraham, Franziska Richter, Sudhakar Subramaniam, Chunni Zhu, Illana Gozes, Raphael Mechoulam, Lia Vorobiev, Melanie B. Watson and Eran Hornstein and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Nature Neuroscience.

In The Last Decade

Iddo Magen

38 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iddo Magen Israel 24 840 617 598 402 334 38 2.0k
Silvia Cerri Italy 26 1.1k 1.3× 584 0.9× 714 1.2× 473 1.2× 127 0.4× 61 2.3k
Marie‐Thérèse Armentero Italy 30 1.1k 1.3× 1.3k 2.1× 796 1.3× 316 0.8× 166 0.5× 52 2.6k
Andreas Plaitakis United States 26 961 1.1× 1.0k 1.6× 800 1.3× 340 0.8× 150 0.4× 54 2.2k
Gilbert Ho United States 21 675 0.8× 718 1.2× 686 1.1× 1.1k 2.7× 223 0.7× 48 2.4k
Wenjie Xie China 23 822 1.0× 723 1.2× 687 1.1× 329 0.8× 151 0.5× 55 2.1k
David Virley United Kingdom 25 339 0.4× 689 1.1× 755 1.3× 467 1.2× 189 0.6× 51 2.1k
Haiyang Jiang China 21 428 0.5× 492 0.8× 809 1.4× 614 1.5× 93 0.3× 40 2.0k
Michał Korostyński Poland 30 345 0.4× 853 1.4× 821 1.4× 833 2.1× 268 0.8× 91 2.5k
Hui Shen United States 27 431 0.5× 1.2k 1.9× 952 1.6× 379 0.9× 392 1.2× 62 3.0k
Anke Witting Germany 22 481 0.6× 928 1.5× 565 0.9× 437 1.1× 1.3k 3.9× 25 2.5k

Countries citing papers authored by Iddo Magen

Since Specialization
Citations

This map shows the geographic impact of Iddo Magen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iddo Magen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iddo Magen more than expected).

Fields of papers citing papers by Iddo Magen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iddo Magen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iddo Magen. The network helps show where Iddo Magen may publish in the future.

Co-authorship network of co-authors of Iddo Magen

This figure shows the co-authorship network connecting the top 25 collaborators of Iddo Magen. A scholar is included among the top collaborators of Iddo Magen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iddo Magen. Iddo Magen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benatar, Michael, Eric A. Macklin, Andrea Malaspina, et al.. (2024). Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis. EBioMedicine. 108. 105323–105323. 14 indexed citations
2.
Magen, Iddo, Jason D. Warren, Carolin Heller, et al.. (2023). microRNA‐based predictor for diagnosis of frontotemporal dementia. Neuropathology and Applied Neurobiology. 49(4). e12916–e12916. 6 indexed citations
3.
Magen, Iddo, Sharon Aharoni, Itay Tokatly Latzer, et al.. (2022). Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients. European Journal of Neurology. 29(8). 2420–2430. 20 indexed citations
4.
Avraham, Yosefa, et al.. (2022). Insulin normalized brain metabolic status on a Model of Anorexia Nervosa in Mice. Physiology & Behavior. 249. 113738–113738. 4 indexed citations
5.
6.
Magen, Iddo, Ariel Ionescu, Noga Gershoni‐Emek, et al.. (2017). ALS Along the Axons – Expression of Coding and Noncoding RNA Differs in Axons of ALS models. Scientific Reports. 7(1). 44500–44500. 75 indexed citations
7.
Richter, Franziska, Sudhakar Subramaniam, Iddo Magen, et al.. (2017). A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-Synuclein. Neurotherapeutics. 14(4). 1107–1119. 48 indexed citations
8.
Malishkevich, Anna, et al.. (2015). Activity-dependent neuroprotective protein (ADNP) exhibits striking sexual dichotomy impacting on autistic and Alzheimer’s pathologies. Translational Psychiatry. 5(2). e501–e501. 83 indexed citations
9.
Magen, Iddo & Illana Gozes. (2014). Davunetide: Peptide Therapeutic in Neurological Disorders. Current Medicinal Chemistry. 21(23). 2591–2598. 40 indexed citations
10.
Magen, Iddo & Eran Hornstein. (2014). Oligonucleotide-based therapy for neurodegenerative diseases. Brain Research. 1584. 116–128. 34 indexed citations
11.
Magen, Iddo & Illana Gozes. (2013). Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: Focus on davunetide (NAP). Neuropeptides. 47(6). 489–495. 38 indexed citations
12.
Wang, L., Iddo Magen, Sudhakar Subramaniam, et al.. (2012). Mice overexpressing wild‐type human alpha‐synuclein display alterations in colonic myenteric ganglia and defecation. Neurogastroenterology & Motility. 24(9). e425–36. 93 indexed citations
13.
Chesselet, Marie‐Françoise, Franziska Richter, Chunni Zhu, et al.. (2012). A Progressive Mouse Model of Parkinson's Disease: The Thy1-aSyn (“Line 61”) Mice. Neurotherapeutics. 9(2). 297–314. 260 indexed citations
14.
Magen, Iddo, Sheila M. Fleming, Chunni Zhu, et al.. (2012). Cognitive deficits in a mouse model of pre‐manifest Parkinson’s disease. European Journal of Neuroscience. 35(6). 870–882. 84 indexed citations
15.
Lam, Hoa A., Nanping Wu, Ingrid Cely, et al.. (2011). Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α‐synuclein. Journal of Neuroscience Research. 89(7). 1091–1102. 132 indexed citations
16.
Magen, Iddo & Marie‐Françoise Chesselet. (2011). Mouse Models of Cognitive Deficits Due to Alpha-Synuclein Pathology. Journal of Parkinson s Disease. 1(3). 217–227. 15 indexed citations
17.
Avraham, Yosefa, Theofilos Poutahidis, Lia Vorobiev, et al.. (2010). Cannabidiol improves brain and liver function in a fulminant hepatic failure‐induced model of hepatic encephalopathy in mice. British Journal of Pharmacology. 162(7). 1650–1658. 80 indexed citations
18.
Magen, Iddo, et al.. (2010). Cannabidiol ameliorates cognitive and motor impairments in bile‐duct ligated mice via 5‐HT1A receptor activation. British Journal of Pharmacology. 159(4). 950–957. 106 indexed citations
19.
Avraham, Yosefa, et al.. (2009). Capsaicin affects brain function in a model of hepatic encephalopathy associated with fulminant hepatic failure in mice. British Journal of Pharmacology. 158(3). 896–906. 31 indexed citations
20.
Avraham, Yosefa, Iddo Magen, Orit Pappo, et al.. (2008). 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist, in various rat tissues during the evolution of experimental cholestatic liver disease. Prostaglandins Leukotrienes and Essential Fatty Acids. 79(1-2). 35–40. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Cerri Breakdown of academic impact, for papers by Marie‐Thérèse Armentero Breakdown of academic impact, for papers by Andreas Plaitakis Breakdown of academic impact, for papers by Gilbert Ho Breakdown of academic impact, for papers by Wenjie Xie Breakdown of academic impact, for papers by David Virley Breakdown of academic impact, for papers by Haiyang Jiang Breakdown of academic impact, for papers by Michał Korostyński Breakdown of academic impact, for papers by Hui Shen Breakdown of academic impact, for papers by Anke Witting
Rankless by CCL
2026